Chemistry:Baxdrostat
From HandWiki
Short description: Chemical compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H25N3O2 |
Molar mass | 363.461 g·mol−1 |
3D model (JSmol) | |
| |
|
Baxdrostat is an investigational drug that is being evaluated for the treatment of hypertension.[1] It is an aldosterone synthase inhibitor.[2][3]
Refences
- ↑ "Baxdrostat - CinCor Pharma". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800054826.
- ↑ "Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension". Current Problems in Cardiology 48 (11): 101918. July 2023. doi:10.1016/j.cpcardiol.2023.101918. PMID 37399857.
- ↑ "Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension". Expert Opinion on Investigational Drugs: 1–11. October 2023. doi:10.1080/13543784.2023.2276755. PMID 37883217.
Original source: https://en.wikipedia.org/wiki/Baxdrostat.
Read more |